"The controlled-release formulation extends our patent protection to 2012 and represents an opportunity to continue to expand our market potential for zileuton by offering a more convenient dosing ...
Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...
Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ...
Please provide your email address to receive an email when new articles are posted on . Two presentations at the 2018 Foundation for Prader-Willi Research Annual Conference in Las Vegas detailed ...
Industry experts share their perspectives on key advances in controlled-release drug delivery and future innovations in this arena. The performance of a drug can often be optimized by controlling the ...
The abstract is available on the ObesityWeek website and can be accessed directly here. About Diazoxide Choline Controlled-Release (DCCR) TabletDiazoxide Choline Controlled-Release tablet is a novel, ...
OxyContin As part of an effort to combat misuse, the FDA has approved updated labeling for Purdue Pharma's reformulated OxyContin controlled-release tablets. The reformulated tablet is more difficult ...
GlaxoSmithKline recently developed a novel technology for the formulation of modified-release tablets. The authors describe the route from development to commercialization. There are a number of ...
Indian Institute of Technology (IIT)-Hyderabad researchers have developed a method to produce controlled-release oral tablets for treating fungal infections and leishmaniasis (Kala Azar or black fever ...
Background and Objective: Oxycodone is a semisynthetic opioid analgesic drug classed as a strong opioid. The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results